Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effect of Duodenal Mucosal Resurfacing (DMR) Using the Revita System in the Treatment of Type 2 Diabetes (T2D)

NCT02879383 is registered in ClinicalTrials.gov with Fractyl Health Inc. as lead sponsor.

NCT NCT02879383
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02879383 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effect of Duodenal Mucosal Resurfacing (DMR) Using the Revita System in the Treatment of Type 2 Diabetes (T2D)
Lead sponsor
Fractyl Health Inc.
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2017
Completion date
December 20, 2019
Enrollment
109 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, noninsulin-dependent diabetes mellitus